WHIRLPOOL CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WHIRLPOOL CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $21.25B | Feb 13, 2018 |
| FY2016 | Dec 31, 2016 | $20.72B | Feb 13, 2017 |
| FY2015 | Dec 31, 2015 | $20.89B | Feb 16, 2016 |
| FY2014 | Dec 31, 2014 | $19.87B | Feb 26, 2015 |
| FY2013 | Dec 31, 2013 | $18.77B | Feb 18, 2014 |
| FY2013 | Dec 31, 2012 | $18.14B | Feb 18, 2014 |
| FY2013 | Dec 31, 2011 | $18.67B | Feb 18, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.52B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $16.61B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $19.46B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $19.72B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $21.99B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $5.80B | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | $5.29B | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | $4.04B | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | $4.33B | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $5.38B | Feb 11, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $5.70B | Feb 13, 2018 |
| FY2017 | Sep 30, 2017 | $5.42B | Feb 13, 2018 |
| FY2017 | Jun 30, 2017 | $5.35B | Feb 13, 2018 |
| FY2017 | Mar 31, 2017 | $4.79B | Feb 13, 2018 |
| FY2016 | Dec 31, 2016 | $5.66B | Feb 13, 2017 |
| FY2017 | Sep 30, 2016 | $5.25B | Feb 13, 2018 |
| FY2017 | Jun 30, 2016 | $5.20B | Feb 13, 2018 |
| FY2016 | Mar 31, 2016 | $4.62B | Feb 13, 2017 |
| FY2015 | Dec 31, 2015 | $5.56B | Feb 16, 2016 |
| FY2015 | Sep 30, 2015 | $5.28B | Feb 16, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.39B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.58B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.17B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $3.07B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $4.41B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $1.36B | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | $1.16B | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | $631.00M | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | $700.00M | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $1.05B | Feb 11, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($323.00M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $481.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($1.52B) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.78B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $497.00M | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | $397.00M | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | $35.00M | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | $152.00M | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $288.00M | Feb 11, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $838.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $143.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.02B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($1.06B) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.35B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $716.00M | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | $570.00M | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | $77.00M | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | $260.00M | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $424.00M | Feb 11, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $370.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $405.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $473.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $465.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $485.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $455.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $541.00M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $572.00M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $596.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $604.00M | Feb 12, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.63B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.68B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.99B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.82B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.08B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $1.88B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.14B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $2.19B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $2.11B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $2.08B | Feb 12, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $470.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $835.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $915.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.39B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.18B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $1.50B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $1.23B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $1.23B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.26B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.20B | Feb 12, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $389.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $451.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $549.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $570.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $525.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $410.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $532.00M | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $590.00M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $684.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $660.00M | Feb 12, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.00B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $16.30B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $17.31B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $17.12B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $20.29B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $20.44B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $18.97B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $18.35B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $20.04B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $19.15B | Feb 12, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.73B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.68B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $2.36B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.34B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $4.85B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $3.89B | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $3.20B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $2.29B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $4.20B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $4.77B | Feb 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.10B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.32B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.33B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $3.33B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.49B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $2.50B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $2.44B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $2.45B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $3.12B | Feb 11, 2020 |
| FY2017 | Dec 31, 2016 | $2.96B | Feb 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.33B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.31B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $8.36B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $8.26B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $10.17B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $8.73B | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $7.87B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $6.93B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $7.35B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $7.31B | Feb 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $669.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.28B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.57B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.96B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $3.04B | Feb 10, 2023 |
| FY2022 | Dec 31, 2020 | $2.92B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $1.95B | Feb 10, 2022 |
| FY2020 | Dec 31, 2018 | $1.50B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.09B | Feb 12, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.17B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.61B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $7.21B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $7.61B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $5.23B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $5.36B | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | $4.70B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $4.99B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $4.77B | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | $4.44B | Feb 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (27) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 28 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 7 | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | 6 | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 4 | Feb 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (27) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 28 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 7 | Feb 11, 2021 |
| FY2020 | Sep 30, 2020 | 6 | Feb 11, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 11, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 4 | Feb 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 55.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 55.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 54.00M | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | 59.00M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | 63.00M | Feb 10, 2022 |
| FY2020 | Dec 31, 2019 | 63.00M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | 64.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | 71.00M | Feb 12, 2019 |
| FY2017 | Dec 31, 2016 | 74.00M | Feb 13, 2018 |